Disrupting the wound care market with innovative skin spray technology
Pacify Medical is a medical technology company focused on advancing wound-healing solutions for plastic surgeons. Their innovative technologies, Skin Spray Technology and Dermadice, significantly reduce surgery time and the amount of donor skin needed, leading to faster healing and shorter hospital stays by enabling clinicians to spray a patient’s own skin cells onto wounds.
Pacify Medical has received several competitive public grants, including the BIRAC BIG Grant, TIDE 2.0, IDEX DIO, and SINE BIRAC Seed, underscoring strong government and institutional support for its innovations. Marquee investors and partners, including SINE IITB, CIIE Initiatives, Citi Bank, ICICI Securities, and HDFC Bank, also back the company.
Pacify Medical holds three patents covering advanced medical devices used in the treatment of large wounds, specifically involving skin micrografting and skin regeneration technologies. These innovations strengthen the company’s intellectual property position in next-generation wound-healing solutions.
Pacify Medical has secured strong institutional confidence, reflected by support from prestigious grants and incubators (including BIRAC BIG, SINE IITB, and IDEX DIO) and funding partners such as Citi Bank, ICICI Securities, and HDFC Bank. The company has also earned notable awards, including the Sustainability Award from the Royal Academy of Engineering (London, 2022), Top 3 Best Pitch at Dassault Systèmes (Paris, 2021), and the Startup Innovation Award at CAHOTECH (2019 & 2020).
We are a team of engineers and designers led by our founder, who has prior experience in developing medical devices, and supported by a distinguished advisory board that includes the former president of the National Burns Association of India and the head of plastic surgery at Sassoon Hospital, among others.
Founder, & CEO
Development lead
Production head
Production Technician
